Supporting antibody quantification in biologic development

8 Sept 2025

Monoclonal antibodies (mAbs) remain one of the most widely used therapeutic modalities across oncology, autoimmune diseases, and infectious diseases.

In this application note, Abselion demonstrates the Amperia™ platform, offering a streamlined alternative, enabling consistent, sensor-based mAb quantification directly from cell culture supernatants using an inverse occupancy assay format, with adaptable throughput and simplified setup.

Amperia™ Protein Quantification System

Abselion

The Amperia™ system combines compact hardware, assay-ready sensors, and integrated software to streamline protein quantification. Built to support scientists in discovery, development, and beyond, it delivers dependable data quickly and without unnecessary complexity — even from crude or complex samples.

(0)

Links

Tags

Supporting antibody quantification in biologic development